CEVEC further strengthens organization to drive industrialization and commercialization of CAP(R) technologies
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene thera…
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene thera…
CEVEC Pharmaceuticals GmbH (CEVEC), führend in der Herstellung von maßgeschneiderten rekombinanten Glykoproteinen und Ge…
CEVECs CAP(R)GT Technologie ermöglicht die vollständig skalierbare Produktion lentiviraler und RCA (replikationskompete…
. - Der Vertrag bezieht sich auf die Nutzung von CEVEC's proprietärer Zelllinie (Expressionssystem) für die Entwicklung…
CEVEC Pharmaceuticals, the developer and licensor of the CAP® Technology, today announced a major milestone regarding it…
CAP-CMV GmbH, a company focusing exclusively on the development of a novel vaccine protecting against human Cytomegalovi…
SIRION Biotech announced today it is now providing viral vectors for preclinical use to be expressed in CEVEC's CAP®-Tec…
SIRION Biotech gab heute bekannt, daß es seine viralen Vektoren für präklinischen Einsatz jetzt auch mithilfe CEVEC's CA…
CEVEC Pharmaceuticals ("CEVEC"), the developer of a novel human expression system derived from amniocytes (CAP® Cells),…
CEVEC Pharmaceuticals ("CEVEC"), the developer of a novel human expression system derived from amniocytes, and Yuhan Cor…